Solara Active Pharma Sciences, the active pharmaceutical ingredient entity of Strides and Sequent, posted a strong operating profit for the June quarter.
Moneycontrol's Shraddha Sharma does a 3-Point Analysis of the company's Q1 numbers and gives a verdict on whether you should buy the stock or not.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
